PHARMACEUTICAL COMPOSITIONS

摘要

A pharmaceutical composition comprising (A) and oligonucleotide having 5 to 50 nucleotide units, which is specifically hybridizable with DNA or RNA derived from a protein kinase C gene, entrapped in (B) sterically stabilised liposomes.